Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the Fexinidazole

African trypanosomiasis

Assessment of Recombinant HAT-RDT Specificity Prospective Evaluation of the Specificity of Serological Tests for Human African Trypanosomiasis Pharmacokinetic, Efficacy, Safety and Tolerability Study of a Single Dose of Acoziborole in g-HAT Paediatric Patients Safety and Tolerability Study of Acoziborole in g-HAT Seropositive Subjects Fexinidazole in Human African Trypanosomiasis Due to T.b. Gambiense at Any Stage Prospective Study on Efficacy and Safety of Acoziborole (SCYX-7158) in Patients Infected by Human African Trypanosomiasis Due to T.b. Gambiense Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the Fexinidazole Diagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: WP3 Post Elimination Monitoring Prospective Evaluation of an RDT to Screen for Gambiense HAT and Diagnose P. Falciparum Malaria Pivotal Study of Fexinidazole for Human African Trypanosomiasis in Stage 2 Diagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: WP2 Passive Case Detection Clinical Study to Assess the Tolerability, Feasibility and Effectiveness of Nifurtimox and Eflornithine (NECT) for the Treatment of Trypanosoma Brucei Gambiense Human African Trypanosomiasis (HAT) in the Meningo-encephalitic Phase Diagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: Early Test-of-cure Trial of DB289 for the Treatment of Stage I African Trypanosomiasis